Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Lowsky

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
Human Immunology|January 14, 2018
Macrochimerism and clinical transplant toleranceJohn D Scandling, Stephan Busque, Robert Lowsky, et al.
Blood|August 27, 2011
Donor immunization with WT1 peptide augments antileukemic activity after MHC-matched bone marrow transplantationHolbrook E Kohrt, Antonia Müller, Jeanette Baker, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 17, 2004
Short tandem repeat analysis to monitor chimerism in macaca fascicularisMacy Lau, Tamara Vayntrub, F Carl Grumet, et al.
Clinical Immunology (Orlando, Fla.)|May 21, 2013
Identification of gene microarray expression profiles in patients with chronic graft-versus-host disease following allogeneic hematopoietic cell transplantationHolbrook E Kohrt, Lu Tian, Li Li, et al.
Bone Marrow Transplantation|August 25, 2024
Effects of donor-engrafted clonal hematopoiesis in allogeneic and autologous stem cell transplantation: a systematic review and meta-analysisYiyu Xie, Vera Kazakova, Lachelle D Weeks, et al.
Haematologica|August 8, 2015
Risks and benefits of sex-mismatched hematopoietic cell transplantation differ according to conditioning strategyHideki Nakasone, Mats Remberger, Lu Tian, et al.
Experimental Hematology|February 26, 2005
CD34, CD4, and CD8 cell doses do not influence engraftment, graft-versus-host disease, or survival following myeloablative human leukocyte antigen-identical peripheral blood allografting for hematologic malignanciesThai M Cao, Ruby M Wong, Kevin Sheehan, et al.
The New England Journal of Medicine|January 25, 2008
Tolerance and chimerism after renal and hematopoietic-cell transplantationJohn D Scandling, Stephan Busque, Sussan Dejbakhsh-Jones, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 6, 2019
Donor-Derived Cytokine-Induced Killer Cell Infusion as Consolidation after Nonmyeloablative Allogeneic Transplantation for Myeloid NeoplasmsRupa Narayan, Jonathan E Benjamin, Omid Shah, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 3, 2017
Validation of the Hematopoietic Cell Transplantation-Specific Comorbidity Index in Nonmyeloablative Allogeneic Stem Cell TransplantationMuthu Veeraputhiran, Lingyao Yang, Vandana Sundaram, et al.
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Human Immunology|January 14, 2018
Macrochimerism and clinical transplant toleranceJohn D Scandling, Stephan Busque, Robert Lowsky, et al.
Blood|August 27, 2011
Donor immunization with WT1 peptide augments antileukemic activity after MHC-matched bone marrow transplantationHolbrook E Kohrt, Antonia Müller, Jeanette Baker, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 17, 2004
Short tandem repeat analysis to monitor chimerism in macaca fascicularisMacy Lau, Tamara Vayntrub, F Carl Grumet, et al.
Clinical Immunology (Orlando, Fla.)|May 21, 2013
Identification of gene microarray expression profiles in patients with chronic graft-versus-host disease following allogeneic hematopoietic cell transplantationHolbrook E Kohrt, Lu Tian, Li Li, et al.
Bone Marrow Transplantation|August 25, 2024
Effects of donor-engrafted clonal hematopoiesis in allogeneic and autologous stem cell transplantation: a systematic review and meta-analysisYiyu Xie, Vera Kazakova, Lachelle D Weeks, et al.
Haematologica|August 8, 2015
Risks and benefits of sex-mismatched hematopoietic cell transplantation differ according to conditioning strategyHideki Nakasone, Mats Remberger, Lu Tian, et al.
Experimental Hematology|February 26, 2005
CD34, CD4, and CD8 cell doses do not influence engraftment, graft-versus-host disease, or survival following myeloablative human leukocyte antigen-identical peripheral blood allografting for hematologic malignanciesThai M Cao, Ruby M Wong, Kevin Sheehan, et al.
The New England Journal of Medicine|January 25, 2008
Tolerance and chimerism after renal and hematopoietic-cell transplantationJohn D Scandling, Stephan Busque, Sussan Dejbakhsh-Jones, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 6, 2019
Donor-Derived Cytokine-Induced Killer Cell Infusion as Consolidation after Nonmyeloablative Allogeneic Transplantation for Myeloid NeoplasmsRupa Narayan, Jonathan E Benjamin, Omid Shah, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 3, 2017
Validation of the Hematopoietic Cell Transplantation-Specific Comorbidity Index in Nonmyeloablative Allogeneic Stem Cell TransplantationMuthu Veeraputhiran, Lingyao Yang, Vandana Sundaram, et al.
Pageof 7